Market Research Logo

Coronary Artery Bypass Graft Surgery - Medical Devices Pipeline Assessment, 2018

Coronary Artery Bypass Graft Surgery - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Coronary Artery Bypass Graft Surgery - Medical Devices Pipeline Assessment, 2018 provides an overview of Coronary Artery Bypass Graft Surgery currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Coronary Artery Bypass Graft Surgery pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Coronary Artery Bypass Graft Surgery under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Coronary Artery Bypass Graft Surgery and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Coronary Artery Bypass Graft Surgery under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Coronary Artery Bypass Graft Surgery Overview
3 Products under Development
3.1 Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development
3.2 Coronary Artery Bypass Graft Surgery - Pipeline Products by Segment
3.3 Coronary Artery Bypass Graft Surgery - Pipeline Products by Territory
3.4 Coronary Artery Bypass Graft Surgery - Pipeline Products by Regulatory Path
3.5 Coronary Artery Bypass Graft Surgery - Pipeline Products by Estimated Approval Date
4 Coronary Artery Bypass Graft Surgery - Pipeline Products under Development by Companies
4.1 Coronary Artery Bypass Graft Surgery Companies - Pipeline Products by Stage of Development
4.2 Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development
5 Coronary Artery Bypass Graft Surgery Companies and Product Overview
5.1 AdvanSource Biomaterials Corporation Company Overview
5.2 Axcelon Biopolymers Corp. Company Overview
5.3 CardioPolymers Inc Company Overview
5.4 Cardious Inc Company Overview
5.5 Centre Hospitalier Universitaire de Nice Company Overview
5.6 Coromedic Ltd. Company Overview
5.7 Cytograft Tissue Engineering Inc (Inactive) Company Overview
5.8 Elana bv Company Overview
5.9 Endogene Ltd Company Overview
5.10 Graft-Loc Inc. Company Overview
5.11 H. Lee Moffitt Cancer Center & Research Institute Inc Company Overview
5.12 Hancock Jaffe Laboratories Inc Company Overview
5.13 Humacyte Inc Company Overview
5.14 iiTech BV Company Overview
5.15 Magenta Medical Inc Company Overview
5.16 McGill University Company Overview
5.17 Miracor Medical Systems GmbH Company Overview
5.18 Neograft Technologies Inc Company Overview
5.19 PetVivo Holdings Inc Company Overview
5.20 Prekubator TTO Company Overview
5.21 RegenMedTX LLC Company Overview
5.22 Rox Medical Inc Company Overview
5.23 SeamVad Ltd. Company Overview
5.24 Thoratec Corp Company Overview
5.25 Tissue Regeneration Technologies LLC Company Overview
5.26 University College London Company Overview
5.27 University of Arizona Company Overview
5.28 University of California Los Angeles Company Overview
5.29 University of Michigan Company Overview
5.30 University of Utah Company Overview
6 Coronary Artery Bypass Graft Surgery- Recent Developments
6.1 May 28, 2018: Beactica Signs Three-Year Extension Agreement With Sanofi
6.2 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results
6.3 May 14, 2018: Autologous Stem Cell Therapy May Hold Key to Regeneration
6.4 May 09, 2018: U.S. Stem Cell Reports First Quarter Results
6.5 May 09, 2018: Sanofi lays off 95 workers in Framingham
6.6 May 08, 2018: Sanofi Announces Appointment of Mr. Charles Billard as Chief Financial Officer and Key Managerial Personnel
6.7 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
6.8 May 02, 2018: Cardiovascular Systems Reports Fiscal 2018 Third-Quarter Financial Results
6.9 Apr 27, 2018: Sanofi: First-quarter 2018 Business EPS up 1.4% at CER
6.10 Apr 26, 2018: AtriCure Reports First Quarter 2018 Financial Results
6.11 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018
6.12 Apr 25, 2018: LeMaitre Q1 2018 Sales $26.0mm (+8%), EPS $0.19 (+17%)
6.13 Apr 25, 2018: KARL STORZ OR1 Operating Rooms - Now Assisting the Surgical Team at Spital Thun, Switzerland
6.14 Apr 24, 2018: Sanofi Head of Global R&D Elias Zerhouni to retire; Company names John Reed to take over on July 1
6.15 Apr 16, 2018: USRM Reports 2017 Financial Results
6.16 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
6.17 Mar 28, 2018: Sanofi: Pre - quarterly Results Communication
6.18 Mar 27, 2018: Moffitt Is Only Cancer Center In Florida Named 2018 LGBTQ Healthcare Equality Leader
6.19 Mar 06, 2018: Sanofi’s Board of Directors Proposes Appointment of Emmanuel Babeau as New Independent Director
6.20 Feb 26, 2018: AtriCure Announces Fourth Quarter and Full Year 2017 Financial Results
6.21 Feb 21, 2018: LeMaitre Reports Net Income Of $4.3mm In Q4 2017
6.22 Feb 20, 2018: AtriCure Names Scott Drake Board Chairman
6.23 Feb 07, 2018: Cardiovascular Systems Reports Fiscal 2018 Second-Quarter Financial Results
6.24 Feb 07, 2018: Sanofi Delivers 2017 Business EPS in line with Guidance
6.25 Feb 06, 2018: USRM Seeing Explosive Increase in Demand for Stem Cell Therapy
6.26 Feb 02, 2018: Cardiovascular Systems Appoints Jeff Points as Chief Financial Officer
6.27 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017
6.28 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
6.29 Jan 24, 2018: Cardiovascular Systems Appoints Rhonda Robb as New Chief Operating Officer
6.30 Jan 19, 2018: Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee
6.31 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017
6.32 Jan 08, 2018: AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2017
6.33 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region
6.34 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results
6.35 Nov 09, 2017: Dextera Surgical Reports Fiscal 2018 First Quarter Financial Results
6.36 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue
6.37 Nov 06, 2017: Ethicon Celebrates 130 Years of Transforming Surgery to Advance Patient Outcomes
6.38 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report
6.39 Nov 02, 2017: Sanofi: Q3 2017 Business EPS up 1.1% at CER FY 2017 Guidance Confirmed
6.40 Nov 01, 2017: AtriCure Reports Third Quarter 2017 Financial Results
6.41 Oct 26, 2017: ROX Medical Announces Sustained Improvements in Patients with Uncontrolled Hypertension Treated with the ROX Coupler
6.42 Oct 26, 2017: LeMaitre Q3 2017 Sales $24.8mm (+7%), Record EPS $0.25 (+49%)
6.43 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017
6.44 Oct 25, 2017: Cardiovascular Systems Reports Fiscal 2018 First-Quarter Financial Results
6.45 Oct 09, 2017: Dextera Surgical’s C-Port Distal Anastomosis System to Be Featured at the 31st Annual European Association for Cardio-Thoracic Surgery
6.46 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria
6.47 Oct 05, 2017: Dextera Surgical Provides Corporate Update
6.48 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary
6.49 Oct 03, 2017: ROX Medical CONTROL HTN-2 Clinical Trial; First Procedure Performed
6.50 Sep 18, 2017: Cardiovascular Systems Announces Anticipated Revenue Impact from Hurricanes Harvey and Irma
6.51 Aug 28, 2017: FDA warns US Stem Cell Clinic of significant deviations
6.52 Aug 28, 2017: U.S. Stem Cell Clinic Acknowledges Warning Letter By The FDA and Responds
6.53 Aug 22, 2017: Medtronic Reports First Quarter Financial Results
6.54 Aug 17, 2017: Dextera Surgical’s Automated Cardiac Anastomotic Device C-Port Distal Anastomosis System to Be Featured at 2017 International Coronary Congress
6.55 Aug 17, 2017: Dextera Surgical’s Automated Cardiac Anastomotic Device PAS-Port System to Be Featured at 2017 International Coronary Congress
6.56 Aug 09, 2017: U.S. Stem Cell Reports Most Successful Financial Performance in the Company's History
6.57 Aug 08, 2017: Dextera Surgical Reports Fiscal 2017 Fourth Quarter Financial Results
6.58 Aug 02, 2017: Cardiovascular Systems Reports Fiscal 2017 Fourth-Quarter Financial Results
6.59 Aug 02, 2017: SAMHSA announces $6 million in grants to support the International President’s Emergency Plan for AIDS Relief Addiction Technology Transfer Centers
6.60 Jul 31, 2017: Sanofi Raises FY 2017 Business EPS Guidance to Broadly Stable at CER
6.61 Jul 27, 2017: LeMaitre Q2 2017 Record Sales $25.8 mm (+15%), Record EPS $0.23 (+69%)
6.62 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017
6.63 Jul 27, 2017: AtriCure Reports Second Quarter 2017 Financial Results
6.64 Jul 18, 2017: AtriCure Announces Hiring of Chief Technology Officer
6.65 Jul 12, 2017: Sanofi: Pre-quarterly Results Communication
6.66 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development
Table 2: Coronary Artery Bypass Graft Surgery - Pipeline Products by Segment
Table 3: Coronary Artery Bypass Graft Surgery - Pipeline Products by Territory
Table 4: Coronary Artery Bypass Graft Surgery - Pipeline Products by Regulatory Path
Table 5: Coronary Artery Bypass Graft Surgery - Pipeline Products by Estimated Approval Date
Table 6: Coronary Artery Bypass Graft Surgery Companies - Pipeline Products by Stage of Development
Table 7: Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development
Table 8: AdvanSource Biomaterials Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 9: CardioPass - Product Status
Table 10: CardioPass - Product Description
Table 11: Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview
Table 12: BNC - PVA Based Vascular Graft - Product Status
Table 13: BNC - PVA Based Vascular Graft - Product Description
Table 14: CardioPolymers Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Plexisyl-AF - Product Status
Table 16: Plexisyl-AF - Product Description
Table 17: Cardious Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: AvA Aortic Valve Bypass Graft System - Product Status
Table 19: AvA Aortic Valve Bypass Graft System - Product Description
Table 20: Centre Hospitalier Universitaire de Nice Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Shark Anastomosis Connector - Product Status
Table 22: Shark Anastomosis Connector - Product Description
Table 23: Coromedic Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Distal Anastomosis Device - Product Status
Table 25: Distal Anastomosis Device - Product Description
Table 26: Proximal Anastomosis Device - Product Status
Table 27: Proximal Anastomosis Device - Product Description
Table 28: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 29: LifeLine TEBV - CABG - Product Status
Table 30: LifeLine TEBV - CABG - Product Description
Table 31: Elana bv Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Artificial Vessel - Product Status
Table 33: Artificial Vessel - Product Description
Table 34: ELANA CLIP 3.0 - Product Status
Table 35: ELANA CLIP 3.0 - Product Description
Table 36: Endogene Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Linear Vascular Anastomosis System - Product Status
Table 38: Linear Vascular Anastomosis System - Product Description
Table 39: Graft-Loc Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Graft-Loc Device - Product Status
Table 41: Graft-Loc Device - Product Description
Table 42: H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 43: Vascular Stent - Product Status
Table 44: Vascular Stent - Product Description
Table 45: Hancock Jaffe Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 46: CoreoGraft - Product Status
Table 47: CoreoGraft - Product Description
Table 48: Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 49: HUMACYL Graft - CABG - Product Status
Table 50: HUMACYL Graft - CABG - Product Description
Table 51: iiTech BV Pipeline Products & Ongoing Clinical Trials Overview
Table 52: S² Distal Anastomotic System - Product Status
Table 53: S² Distal Anastomotic System - Product Description
Table 54: S² Proximal Anastomotic System - Product Status
Table 55: S² Proximal Anastomotic System - Product Description
Table 56: Magenta Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 57: Magenta Device - Congestive Heart Failure - Product Status
Table 58: Magenta Device - Congestive Heart Failure - Product Description
Table 59: McGill University Pipeline Products & Ongoing Clinical Trials Overview
Table 60: Transcatheter Aorta Pulmonary Shunt - Product Status
Table 61: Transcatheter Aorta Pulmonary Shunt - Product Description
Table 62: Miracor Medical Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 63: PiCSOAMI Impulse Console - CABG - Product Status
Table 64: PiCSOAMI Impulse Console - CABG - Product Description
Table 65: Neograft Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 66: Angioshield - Product Status
Table 67: Angioshield - Product Description
Table 68: PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 69: Coronary Artery Bypass Graft - Product Status
Table 70: Coronary Artery Bypass Graft - Product Description
Table 71: Prekubator TTO Pipeline Products & Ongoing Clinical Trials Overview
Table 72: Snapcon - Product Status
Table 73: Snapcon - Product Description
Table 74: RegenMedTX LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 75: Neo-Vessel Replacement - Coronary Artery Bypass - Product Status
Table 76: Neo-Vessel Replacement - Coronary Artery Bypass - Product Description
Table 77: Rox Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 78: ROX Anastomotic Coupler System - Product Status
Table 79: ROX Anastomotic Coupler System - Product Description
Table 80: SeamVad Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 81: MySide - Product Status
Table 82: MySide - Product Description
Table 83: Thoratec Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 84: Automated Anastomosis Device - Product Status
Table 85: Automated Anastomosis Device - Product Description
Table 86: Tissue Regeneration Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 87: Cardiogold - Product Status
Table 88: Cardiogold - Product Description
Table 89: University College London Pipeline Products & Ongoing Clinical Trials Overview
Table 90: Small Diameter Conduit - Product Status
Table 91: Small Diameter Conduit - Product Description
Table 92: University of Arizona Pipeline Products & Ongoing Clinical Trials Overview
Table 93: Vascular Anastomosis Device - Product Status
Table 94: Vascular Anastomosis Device - Product Description
Table 95: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
Table 96: Sutureless Anastomosis Device - Product Status
Table 97: Sutureless Anastomosis Device - Product Description
Table 98: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
Table 99: Arterial Everter - Product Status
Table 100: Arterial Everter - Product Description
Table 101: University of Utah Pipeline Products & Ongoing Clinical Trials Overview
Table 102: Automated Arterial Anastomotic Device - Product Status
Table 103: Automated Arterial Anastomotic Device - Product Description
Table 104: Glossary
1.2 List of Figures
Figure 1: Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development
Figure 2: Coronary Artery Bypass Graft Surgery - Pipeline Products by Segment
Figure 3: Coronary Artery Bypass Graft Surgery - Pipeline Products by Territory
Figure 4: Coronary Artery Bypass Graft Surgery - Pipeline Products by Regulatory Path
Figure 5: Coronary Artery Bypass Graft Surgery - Pipeline Products by Estimated Approval Date

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report